Salud

Comisión Nacional de Vacunación ve difícil venta de vacuna contra covid-19 en comercios a corto plazo

Roberto Arroba, secretario técnico de ese órgano, explicó que por tratarse de productos con aprobación de emergencia, el registro es un proceso mucho más complicado; Pfizer niega tratos con oferentes privados

(FILES) This file photograph taken on March 30, 2021, shows vials of the Pfizer/BioNTech vaccine in a cold room before being packaged for shipping at an AGEPS (Agence Generale des Equipements et Produits de Sante - General Agency for Health Equipment and Products ) of the Paris public hospitals (AP-HP) warehouse in the Paris suburbs, amidst the coronavirus (Covid-19) pandemic. - The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, European Commission chief Ursula von der Leyen said April 14, 2021. (Photo by JOEL SAGET / AFP)
(FILES) This file photograph taken on March 30, 2021, shows vials of the Pfizer/BioNTech vaccine in a cold room before being packaged for shipping at an AGEPS (Agence Generale des Equipements et Produits de Sante - General Agency for Health Equipment and Products ) of the Paris public hospitals (AP-HP) warehouse in the Paris suburbs, amidst the coronavirus (Covid-19) pandemic. - The EU is turning more heavily to BioNTech/Pfizer to make up for suspended Johnson & Johnson vaccine doses and for longer-term needs to fight the mutating coronavirus, European Commission chief Ursula von der Leyen said April 14, 2021. (Photo by JOEL SAGET / AFP) JOEL SAGET
‌
‌

‌

‌
‌

‌

‌